Effect of a closure device on complication rates in high-local-risk patients: Results of a randomized multicenter trial
โ Scribed by Bernard Chevalier; Bernard Lancelin; Rene Koning; Michel Henry; Antoine Gommeaux; Remy Pilliere; Meyer Elbaz; Thierry Lefevre; Kamel Boughalem; Jean Marco; Patrick Dupouy
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 75 KB
- Volume
- 58
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This study tested the hypothesis that high-dose peginterferon alfa-2a (PEG-IFNalpha-2a) for the first 12 weeks would increase early and sustained virological response (SVR) rates in patients with chronic hepatitis C genotype 1. Eight hundred ninety-six patients were randomized 1:1 to 360 microg (n =
The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place